Incarcerated individuals, who are overrepresented among those infected with HIV, experience multiple barriers to optimal antiretroviral therapy (ART) adherence after incarceration. Substance use is highly prevalent among legal system-involved individuals and is commonly associated with suboptimal medication adherence. This manuscript describes the development and pilot test results of two interventions designed to improve ART adherence among formerly incarcerated individuals living with HIV (PLWH). Thirty participants were randomized and completed a multi-session ART adherence and risk reduction intervention or a brief ART adherence intervention. Participants were interviewed at baseline, 1-month, and 3-month follow-up. While past 30-day ART adherence improved in both groups, participants in the brief intervention group took a higher proportion of their ART medication. Multi-session intervention group participants experienced greater reductions in substance use and problematic experiences associated with drug use. ART medication adherence interventions can potentially improve treatment outcomes among PLWH who experience incarceration.
AlegriaM.AlvarezK.IshikawaR. Z.DiMarzioK.McPeckS. (2016). Removing obstacles to eliminating racial and ethnic disparities in behavioral health care. Health Affairs, 35(6), 991–999. https://doi.org/10.1377/hlthaff.2016.0029
2.
AmicoK. R.HarmanJ. J.JohnsonB. T. (2006). Efficacy of antiretroviral therapy adherence interventions. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(3), 285–297. https://doi.org/10.1097/01.qai.0000197870.99196.ea
3.
AttiaS.EggerM.MüllerM.ZwahlenM.LowN. (2009). Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS, 23(11), 1397–1404. https://doi.org/10.1097/QAD.0b013e32832b7dca
4.
BaillargeonJ.GiordanoT. P.RichJ. D.WuZ. H.WellsK.PollockB. H.PaarD. P. (2009). Accessing antiretroviral therapy following release from prison. JAMA, 301(8), 848–857. https://doi.org/10.1001/jama.2009.202
5.
BarnettF.YauM.GrayM. (2014). The efficacy of a group-based exercise and sexuality education program for prostate cancer survivors. Rehabilitation Oncology, 32(4), 45–51. https://doi.org/10.1097/01893697-201432040-00008
6.
BezabheW. M.ChalmersL.BereznickiL. R.PetersonG. M. (2016). Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine, 95(15), e3361. https://doi.org/10.1097/md.0000000000003361
7.
BookerC. A.FlygareC. T.SolomonL.BallS. W.PustellM. R.BazermanL. B.Simon-LevineD.TeixeiraP. A.Cruzado-QuinonesJ.KlingR. N.FrewP. M.SpauldingA. C., & EnhanceLink Study Group. (2013). Linkage to HIV care for jail detainees: Findings from detention to the first 30 days after release. AIDS and Behavior, 17(Suppl 2), S128–S136. https://doi.org/10.1007/s10461-012-0354-3
8.
CarsonA. E. (2021). Prisoners in 2020. Department of Justice, Bureau of Justice Statistics, NCJ 302776.
9.
CastillaJ.del RomeroJ.HernandoV.MarincovichB.GarcíaS.RodríguezC. (2005). Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes, 40(1), 96–101. https://doi.org/10.1097/01.qai.0000157389.78374.45
10.
ChaiyachatiK. H.OgbuojiO.PriceM.SutharA. B.NegussieE. K.BarnighausenT. (2014). Interventions to improve adherence to antiretroviral therapy: A rapid systematic review. AIDS, 28(Suppl 2), S187–S204. https://doi.org/10.1097/QAD.0000000000000252
11.
ChamberlainA.NyamuS.AminawungJ.WangE. A.ShavitS.FoxA. D. (2019). Illicit substance use after release from prison among formerly incarcerated primary care patients: A cross-sectional study. Addiction Science and Clinical Practice, 14(1), 7. https://doi.org/10.1186/s13722-019-0136-6
12.
CoeS.FranssenM.CollettJ.BoyleD.MeaneyA.ChantryR.EsserP.IzadiH.DawesH. (2018). Physical activity, fatigue, and sleep in people with Parkinson’s disease: A secondary per protocol analysis from an intervention trial. Parkinson’s Disease, 2018, 1–6. https://doi.org/10.1155/2018/1517807
13.
CohenM. S.ChenY. Q.McCauleyM.GambleT.HosseinipourM. C.KumarasamyN.HakimJ. G.KumwendaJ.GrinsztejnB.PilottoJ. H. S.GodboleS. V.MehendaleS.ChariyalertsakS.SantosB. R.MayerK. H.HoffmanI. F.EshlemanS. H.Piwowar-ManningE.WangL., … FlemingT. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. https://doi.org/10.1056/nejmoa1105243
14.
CopenhaverM.ChowdhuryS.AticeF. L. (2009). Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: The process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention. AIDS Patient Care and STDs, 23(4), 277–288. https://doi.org/10.1089/apc.2008.0157
15.
CorscaddenL.LevesqueJ. F.LewisV.StrumpfE.BretonM.RussellG. (2018). Factors associated with multiple barriers to access to primary care: an international analysis. International Journal for Equity in Health, 17(1), 28. https://doi.org/10.1186/s12939-018-0740-1
16.
CunninghamW. E.WeissR. E.NakazonoT.MalekM. A.ShoptawS. J.EttnerS. L.HarawaN. T. (2018). Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail: The LINK LA randomized clinical trial. JAMA Internal Medicine, 178(4), 542–553. https://doi.org/10.1001/jamainternmed.2018.0150
17.
de AndradeD.RitchieJ.RowlandsM.MannE.HidesL. (2018). Substance use and recidivism outcomes for prison-based drug and alcohol interventions. Epidemiologic Reviews, 40(1), 121–133. https://doi.org/10.1093/epirev/mxy004
18.
Del RomeroJ.CastillaJ.HernandoV.RodríguezC.GarcíaS. (2010). Combined antiretroviral treatment and heterosexual transmission of HIV-1: Cross sectional and prospective cohort study. BMJ, 340, c2205. http://doi.org/10.1136/bmj.c2205
19.
DennisA. C.BarringtonC.HinoS.GouldM.WohlD.GolinC. E. (2015). “You’re in a world of chaos”: Experiences accessing HIV care and adhering to medications after incarceration. The Journal of the Association of Nurses in AIDS Care, 26(5), 542–555. https://doi.org/10.1016/j.jana.2015.06.001
20.
DiPreteB. L.PenceB. W.GolinC. E.KnightK.FlynnP. M.Carda-AutenJ.GrovesJ. S.PowersK. A.WhiteB. L.NapravnikS.WohlD. A. (2019). Antiretroviral adherence following prison release in a randomized trial of the imPACT intervention to maintain suppression of HIV viremia. AIDS and Behavior, 23(9), 2386–2395. https://doi.org/10.1007/s10461-019-02488-7
21.
DobkinP. L.DeC. M.ParaherakisA.GillK. (2002). The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers. Addiction, 97(3), 347–356. https://doi.org/10.1046/j.1360-0443.2002.00083.x
22.
DolanK.CarrJ. L. (2015). The poor get prison: The alarming spread of the criminalization of poverty. Institute for Policy Studies.
23.
DonnellD.BaetenJ. M.KiarieJ.ThomasK. K.StevensW.CohenC. R.McIntyreJ.LingappaJ. R.CelumC. (2010). Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. The Lancet, 375(9731), 2092–2098. https://doi.org/10.1016/s0140-6736(10)60705-2
24.
DurhamS. H.ChahineE. B. (2021). Cabotegravir-rilpivirine: The first complete long-acting injectable regimen for the treatment of HIV-1 infection. Annals of Pharmacotherapy, 55(11), 1397–1409. https://doi.org/10.1177/1060028021995586
25.
DuttaA.WirtzA. L.BaralS.BeyrerC.CleghornF. R. (2012). Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries. Current Opinion in HIV and AIDS, 7(4), 362–368. https://doi.org/10.1097/COH.0b013e328354a0b5
26.
EgedeL. E.WilliamsJ. S.VoroncaD. C.GebregziabherM.LynchC. P. (2017). Telephone-delivered behavioral skills intervention for African American adults with type 2 diabetes: A randomized controlled trial. Journal of General Internal Medicine, 32(7), 775–782. https://doi.org/10.1007/s11606-017-4023-0
27.
FeldmanB. J.FredericksenR. J.CraneP. K.SafrenS. A.MugaveroM. J.WilligJ. H.SimoniJ. M.WilsonI. B.SaagM. S.KitahataM. M.CraneH. M. (2013). Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS and Behavior, 17(1), 307–318. https://doi.org/10.1007/s10461-012-0326-7
28.
FuJ. J.HermeM.WickershamJ. A.ZelenevA.AlthoffA.ZallerN. D.BazaziA. R.AveryA. K.PorterfieldJ.JordanA. O.Simon-LevineD.LymanM.AlticeF. L. (2013). Understanding the revolving door: Individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS and Behavior, 17(02), S145–S155. https://doi.org/10.1007/s10461-013-0590-1
29.
FugeT. G.TsourtosG.MillerE. R. (2020). A systematic review and meta-analyses on initiation, adherence and outcomes of antiretroviral therapy in incarcerated people. PLoS One, 15(5), e0233355. https://doi.org/10.1371/journal.pone.0233355
30.
GilbertL.El-BasselN.ManuelJ.WuE.GoH.GolderS.SeewaldR.SandersG. (2006). An integrated relapse prevention and relationship safety intervention for women on methadone: Testing short-term effects on intimate partner violence and substance use. Violence and Victims, 21(5), 657–672.
31.
GonzalezA.BarinasJ.CleirighC. (2011). Substance use: Impact on adherence and HIV medical treatment. Current HIV/AIDS Reports, 8, 223–234.
32.
GwadzM.ClelandC. M.ApplegateE.BelkinM.GandhiM.SalomonN.BanfieldA.LeonardN.RiedelM.WolfeH.PickensI.BolgerK.BowensD.PerlmanD.MildvanD., & The Heart to Heart Collaborative Research Team. (2015). Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: A randomized controlled trial of a novel intervention. AIDS and Behavior, 19(10), 1801–1817. https://doi.org/10.1007/s10461-015-1054-6
33.
HåkanssonA.BerglundM. (2012). Risk factors for criminal recidivism – A prospective follow-up study in prisoners with substance abuse. BMC Psychiatry, 12(1), 111. https://doi.org/10.1186/1471-244X-12-111
34.
HåkanssonA.JesionowskaV. (2018). Associations between substance use and type of crime in prisoners with substance use problems – A focus on violence and fatal violence. Substance Abuse and Rehabilitation, 9, 1–9. https://doi.org/10.2147/SAR.S143251
35.
HaleyD. F.GolinC. E.FarelC. E.WohlD. A.ScheyettA. M.GarrettJ. J.RosenD. L.ParkerS. D. (2014). Multilevel challenges to engagement in HIV care after prison release: A theory-informed qualitative study comparing prisoner’ perspectives before and after community reentry. BMC Public Health, 14, 1253. https://doi.org/10.1186/1471-2458-14-1253
36.
HaslamC.HaslamS. A.JettenJ.BevinsA.RavenscroftS.TonksJ. (2010). The social treatment: The benefits of group interventions in residential care settings. Psychology and Aging, 25(1), 157–167. https://doi.org/10.1037/a0018256
37.
HeslinK. C.SingzonT. K.FarmerM.DobalianA.TsaoJ.HamiltonA. B. (2013). Therapy or threat? Inadvertent exposure to alcohol and illicit drug cues in the neighbourhoods of sober living homes. Health & Social Care in the Community, 21(5), 500–508. https://doi.org/10.1111/hsc.12040
38.
HuntD. E.KlingR.AlmozlinoY.JalbertS.ChapmanM. T.RhodesW. (2015). Telling the truth about drug use. Journal of Drug Issues, 45(3), 314–329. https://doi.org/10.1177/0022042615589406
39.
HydeJ.ApplebyP. R.WeissG.BaileyJ.MorganX. (2005). Group-level interventions for persons living with HIV: A catalyst for individual change. AIDS Education and Prevention, 17(1 Suppl A), 53–65. https://doi.org/10.1521/aeap.17.2.53.58699
40.
IacobS. A.IacobD. G.JuguleteG. (2017). Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment – Clinical points of view and practical considerations. Frontiers in Pharmacology, 8, 831. https://doi.org/10.3389/fphar.2017.00831
41.
IngersollK. S.DillinghamR. A.HettemaJ. E.ConawayM.FreemanJ.ReynoldsG.HosseinborS. (2015). Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV. Health Psychology, 34S, 1305–1315. https://doi.org/10.1037/hea0000295
42.
IrohP. A.MayoH.NijhawanA. E. (2015). The HIV care cascade before, during, and after incarceration: A systematic review and data synthesis. American Journal of Public Health, 105(7), e5–e16. https://doi.org/10.2105/AJPH.2015.302635
43.
JarbandhanA.ToelsieJ.VeegerD.BipatR.VanheesL.BuysR. (2022). Feasibility of a home-based physiotherapy intervention to promote post-stroke mobility: A randomized controlled pilot study. PloS One, 17(3), e0256455. https://doi.org/10.1371/journal.pone.0256455
44.
JonesD. L.McPherson-BakerS.LydstonD.CamilleJ.BrondoloE.TobinJ. N.WeissS. M. (2007). Efficacy of a group medication adherence intervention among HIV positive women: The SMART/EST Women’s Project. AIDS and Behavior, 11(1), 79–86. https://doi.org/10.1007/s10461-006-9165-8
45.
KalichmanS. C.CherryC.KalichmanM. O.AmaralC. M.WhiteD.PopeH.SwetzesC.EatonL.MacyR.CainD. (2011). Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission. American Journal of Public Health, 101(3), 531–538. https://doi.org/10.2105/ajph.2010.197608
46.
KalichmanS. C.GreblerT.AmaralC. M.McnerneyM.WhiteD.KalichmanM. O.CherryC.EatonL. (2014). Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults. International Journal of Behavioral Medicine, 21(5), 811–820. https://doi.org/10.1007/s12529-013-9353-7
47.
KalichmanS. C.RamachandranB.CatzS. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14(5), 267–273. https://doi.org/10.1046/j.1525-1497.1999.00334.x
48.
KatzI. T.RyuA. E.OnuegbuA. G.PsarosC.WeiserS. D.BangsbergD. R.TsaiA. C. (2013). Impact of HIV-related stigma on treatment adherence: Systematic review and meta-synthesis. Journal of the International AIDS Society, 16(3 Suppl 2), 18640. https://doi.org/10.7448/IAS.16.3.18640
49.
KatzenA. L. (2011). African American men’s health and incarceration: Access to care upon reentry and eliminating invisible punishments. Berkeley Journal of Gender, Law and Justice, 26, 221.
50.
KoneruS.ShishovM.WareA.FarheyY.MongeyA. B.GrahamT. B.PassoM. H.HoukJ. L.HigginsG. C.BrunnerH. I. (2007). Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis & Rheumatology, 57(6), 1000–1006. https://doi.org/10.1002/art.22898
51.
KulkarniS. P.BaldwinS.LightstoneA. S.GelbergL.DiamantA. L. (2010). Is incarceration a contributor to health disparities? Access to care of formerly incarcerated adults. Journal of Community Health, 35(3), 268–274. https://doi.org/10.1007/s10900-010-9234-9
52.
LambersF. A.StolteI. G.van den BergC. H.CoutinhoR. A.PrinsM. (2011). Harm reduction intensity - Its role in HAART adherence amongst drug users in Amsterdam. International Journal of Drug Policy, 22(3), 210–218. https://doi.org/10.1016/j.drugpo.2011.02.004
53.
LangebeekN.GisolfE. H.ReissP.VervoortS. C.HafsteinsdóttirT. B.RichterC.SprangersM.NieuwkerkP. T. (2014). Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Medicine, 12(1), 142. https://doi.org/10.1186/preaccept-1453408941291432
54.
LiuH.MillerL. G.HaysR. D.GolinC. E.WuT.WengerN. S.KaplanA. H. (2006). Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. JAIDS Journal of Acquired Immune Deficiency Syndrome, 41(3), 315–322. https://doi.org/10.1097/01.qai.0000197071.77482.6e
55.
LoeligerK. B.AlticeF. L.DesaiM. M.CiarleglioM. M.GallagherC.MeyerJ. P. (2018). Predictors of linkage to HIV care and viral suppression after release from jails and prisons: A retrospective cohort study. The Lancet HIV, 5(2), e96–e106. https://doi.org/10.1016/s2352-3018(17)30209-6
56.
LoutfyM. R.WuW.LetchumananM.BondyL.AntoniouT.MargoleseS.ZhangY.RuedaS.McGeeF.PeckR.BinderL.AllardP.RourkeS. B.RochonP. A. (2013). Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS ONE, 8(2), e55747. https://doi.org/10.1371/journal.pone.0055747
57.
LucasG. M.ChaudhryA.HsuJ.WoodsonT.LauB.OlsenY.KerulyJ. C.FiellinD. A.FinkelsteinR.Barditch-CrovoP.CookK.MooreR. D. (2010). Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Annals of Internal Medicine, 152(11), 704–711. https://doi.org/10.7326/0003-4819-152-11-201006010-00003
58.
McCabeS. E.CranfordJ. A.MoralesM.YoungA. (2006). Simultaneous and concurrent polydrug use of alcohol and prescription drugs: Prevalence, correlates, and consequences. Journal of Studies on Alcohol, 67(4), 529–537. https://doi.org/10.15288/jsa.2006.67.529
59.
MetschL. R.FeasterD. J.GoodenL.MathesonT.StitzerM.DasM.JainM. K.RodriguezA. E.ArmstrongW. S.LucasG. M.NijhawanA. E.DrainoniM. L.HerreraP.Vergara-RodriguezP.JacobsonJ. M.MugaveroM. J.SullivanM.DaarE. S.McMahonD. K. , … del RioC. (2016). Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: A randomized clinical trial. JAMA, 316(2), 156–170. https://doi.org/10.1001/jama.2016.8914
60.
MeyerJ. P.CepedaJ.WuJ.TrestmanR. L.AlticeF. L.SpringerS. A. (2014). Optimization of human immunodeficiency virus treatment during incarceration: Viral suppression at the prison gate. JAMA Internal Medicine, 174(5), 721–729. https://doi.org/10.1001/jamainternmed.2014.601
61.
MimiagaM. J.ClossonE. F.BielloK. B.NguyenH.NguyenQ. H.OldenburgC. E.LanH. T.SafrenS. A.MayerK. H.ColbyD. J. (2016). A group-based sexual risk reduction intervention for men who have sex with men in Ho Chi Minh City, Vietnam: Feasibility, acceptability, and preliminary efficacy. Archives of Sexual Behavior, 45(6), 1493–1500. https://doi.org/10.1007/s10508-015-0663-5
62.
MkuuR.Rowell-CunsoloT. L.IdokoE.HarveyI. (2019). “Until I get off parole…then I can swim in it if I want to”: Facilitators and barriers of drug use among formerly incarcerated Black drug offenders. Journal of Ethnicity in Substance Abuse, 18, 3–22.
63.
MoherM.EricksonM.BlackP.PriceM.FraserC.NormanW. V.GuillemiS.PickN.Elwood MartinR. (2022). Improving post-release care engagement for people living HIV involved in the criminal justice system: A systematic review. AIDS and Behavior, 26(5), 1607–1617. https://doi.org/10.1007/s10461-021-03513-4
64.
MyersJ. J.Kang DufourM. S.KoesterK. A.MorewitzM.PackardR.Monico KleinK.EstesM.WilliamsB.RikerA.TulskyJ. (2018). The effect of patient navigation on the likelihood of engagement in clinical care for HIV-infected individuals leaving jail. American Journal of Public Health, 108(3), 385–392. https://doi.org/10.2105/AJPH.2017.304250
65.
NicholasP. K.WillardS.ThompsonC.Dawson-RoseC.CorlessI. B.WantlandD. J.SefcikE. F.NokesK. M.KirkseyK. M.HamiltonM. J.HolzemerW. L.PortilloC. J.Rivero MendezM.RobinsonL. M.RosaM.HumanS. P.CucaY.HuangE.MarylandM., … MoezziS. (2014). Engagement with care, substance use, and adherence to therapy in HIV/AIDS. AIDS Research and Treatment, 2014, 675739. https://doi.org/10.1155/2014/675739
66.
OwensM. D.ChenJ. A.SimpsonT. L.TimkoC.WilliamsE. C. (2018). Barriers to addiction treatment among formerly incarcerated adults with substance use disorders. Addiction Science & Clinical Practice, 13(1), 19. https://doi.org/10.1186/s13722-018-0120-6
67.
ParsonsJ. T.JohnS. A.MillarB. M.StarksT. J. (2018). Testing the efficacy of combined motivational interviewing and cognitive behavioral skills training to reduce methamphetamine use and improve HIV medication adherence among HIV-positive gay and bisexual men. AIDS and Behavior, 22(8), 2674–2686. https://doi.org/10.1007/s10461-018-2086-5
68.
RaffaJ.TossonianH. K.GrebelyJ.PetkauA. J.DeVlamingS.ConwayB. (2008). Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47(3), 397–399. https://doi.org/10.1097/QAI.0b013e31815b0d35
69.
ReznickO. G.McCartneyK.GregorichS. E.ZackB.FeasterD. J. (2013). An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community. Journal of Correctional Health Care, 19(3), 178–193. https://doi.org/10.1177/1078345813486442
70.
RichJ. D.DiClementeR.LevyJ.LydaK.RuizM. S.RosenD. L.DumontD., Centers for AIDS Research at the Social and Behavioral Sciences Research Network, & Centers for AIDS Research–Collaboration on HIV in Corrections Working Group. (2013). Correctional facilities as partners in reducing HIV disparities. Journal of Acquired Immune Deficiency Syndromes, 63(Suppl 1), S49–S53. https://doi.org/10.1097/QAI.0b013e318292fe4c
71.
RintamakiL. S.DavisT. C.SkripkauskasS.BennettC. L.WolfM. S. (2006). Social stigma concerns and HIV medication adherence. AIDS Patient Care and STDs, 20(5), 359–368. https://doi.org/10.1089/apc.2006.20.359
72.
Rowell-CunsoloT. L.HongH. K.MkuuR.BrittonA. (2020a). Improving medication adherence among drug-using HIV-infected formerly incarcerated individuals: A pilot test of two interventions. Journal of Correctional Health Care, 26(1), 42–54. https://doi.org/10.1177/1078345819897634
73.
Rowell-CunsoloT. L.HuG. (2020). Barriers to optimal antiretroviral therapy adherence among HIV-infected formerly incarcerated individuals in New York City. PLoS One, 15(6), e0233842. https://doi.org/10.1371/journal.pone.0233842
74.
Rowell-CunsoloT. L.HuG.HaileR. (2020b). It's like I was out there by myself": The receipt of reentry support among HIV-infected formerly incarcerated individuals in New York City. Health Justice, 8(1), 6. https://doi.org/10.1186/s40352-020-00108-4
75.
Rowell-CunsoloT. L.MkuuR.BelleroseM.WechsbergW. (2022). “I said maybe we should use a condom, and then that just went south”: Understanding condom use among formerly incarcerated Black Americans in New York City, USA. Journal of Sex Research.
76.
Rowell-CunsoloT. L.SzetoB.McDonaldC.El-BasselN. (2018). Return to illicit drug use post-incarceration among formerly incarcerated Black Americans. Drugs, 25(3), 234–240. https://doi.org/10.1080/09687637.2016.1259391
77.
SametJ. H.BlokhinaE.ChengD. M.WalleyA. Y.LioznovD.GnatienkoN.QuinnE. K.BriddenC.ChaissonC. E.ToussovaO.GiffordA. L.RajA.KrupitskyE. (2019). A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care. AIDS, 33(9), 1467–1476. https://doi.org/10.1097/QAD.0000000000002230
78.
SanderG.Shirley-BeavanS.StoneK. (2019). The global state of harm reduction in prisons. Journal of Correctional Health Care, 25(2), 105–120. https://doi.org/10.1177/1078345819837909
79.
SimoniJ. M.AmicoK. R.SmithL.NelsonK. (2010). Antiretroviral adherence interventions: Translating research findings to the real world clinic. Current HIV/AIDS Reports, 7(1), 44–51. https://doi.org/10.1007/s11904-009-0037-5
SorensenJ. L.HaugN. A.LariosS.GruberV. A.TulskyJ.PowelsonE.LoganD. P.ShapiroB. (2012). Directly administered antiretroviral therapy: Pilot study of a structural intervention in methadone maintenance. Journal of Substance Abuse Treatment, 43(4), 418–423. https://doi.org/10.1016/j.jsat.2012.08.014
82.
SpaanP.van LuenenS.GarnefskiN.KraaijV. (2020). Psychosocial interventions enhance HIV medication adherence: A systematic review and meta-analysis. Journal of Health Psychology, 25(10–11), 1326–1340. https://doi.org/10.1177/1359105318755545
83.
SpringerS. A.PesantiE.HodgesJ.MacuraT.DorosG.AlticeF. L. (2004). Effectiveness of antiretroviral therapy among HIV-infected prisoners: Reincarceration and the lack of sustained benefit after release to the community. Clinical Infectious Diseases, 38(12), 1754–1760.
84.
StarksT. J.SkeenS. J.Scott JonesS.GurungS.MillarB. M.FerrarisC.VentuneacA.ParsonsJ. T.SparksM. A. (2022). Effectiveness of a combined motivational interviewing and cognitive behavioral intervention to reduce substance use and improve HIV-related immune functioning. AIDS and Behavior, 26(4), 1138–1152. https://doi.org/10.1007/s10461-021-03467-7
85.
StephensonB. L.WohlD. A.GolinC. E.TienH.-C.StewartP.KaplanA. H. (2005). Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Reports, 120(1), 84–88. http://www.jstor.org/stable/20056751.
86.
StoneJ.FraserH.LimA. G.WalkerJ. G.WardZ.MacGregorL.TrickeyA.AbbottS.StrathdeeS. A.AbramovitzD.MaherL.IversenJ.BruneauJ.ZangG.GarfeinR. S.YenY.-F.AzimT.MehtaS. H.MilloyM.-J., … VickermanP. (2018). Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: A systematic review and meta-analysis. The Lancet Infectious Diseases, 18(12), 1397–1409. https://doi.org/10.1016/s1473-3099(18)30469-9
87.
TchakouteC. T.RheeS.-Y.HareC. B.ShaferR. W.SainaniK. (2022). Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system. PLoS One, 17(2), e0263742. https://doi.org/10.1371/journal.pone.0263742
88.
TraversJ. L.CohenC. C.DickA. W.StoneP. W. (2017). The Great American Recession and forgone healthcare: Do widened disparities between African-Americans and Whites remain?PLoS One, 12(12), e0189676. https://doi.org/10.1371/journal.pone.0189676
89.
TrepkaM. J.NiyonsengaT.FennieK. P.McKelveyK.LiebS.MaddoxL. M. (2015). Sex and racial/ethnic differences in premature mortality due to HIV: Florida, 2000-2009. Public Health Reports, 130(5), 505–513. https://doi.org/10.1177/003335491513000513
90.
UnderhillK.DumontD.OperarioD. (2014). HIV prevention for adults with criminal justice involvement: A systematic review of HIV risk-reduction interventions in incarceration and community settings. American Journal of Public Health, 104(11), e27–e53. https://doi.org/10.2105/AJPH.2014.302152
91.
Villalobos-GallegosL.PérezA.MendozaR.GraueJ.Marín-NavarreteR. (2015). Psychometric and diagnostic properties of the Drug Abuse Screening Test (DAST): Comparing the DAST-20 vs. the DAST-10. Salud Mental, 38(2), 89–94. https://doi.org/10.17711/sm.0185-3325.2015.012
92.
WalshJ. C.MandaliaS.GazzardB. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16(2), 269–277. https://doi.org/10.1097/00002030-200201250-00017
93.
WestergaardR. P.SpauldingA. C.FlaniganT. P. (2013). HIV among persons incarcerated in the USA: A review of evolving concepts in testing, treatment, and linkage to community care. Current Opinion in Infectious Diseases, 26(1), 10–16. https://doi.org/10.1097/QCO.0b013e32835c1dd0
94.
WhiteheadA. L.JuliousS. A.CooperC. L.CampbellM. J. (2016). Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Statistical Methods in Medical Research, 25(3), 1057–1073. https://doi.org/10.1177/0962280215588241
95.
WohlD. A.ScheyettA.GolinC. E.WhiteB.MatuszewskiJ.BowlingM.SmithP.DuffinF.RosenD.KaplanA.EarpJ. (2011). Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: A randomized trial. AIDS and Behavior, 15(2), 356–364. https://doi.org/10.1007/s10461-010-9843-4
96.
WolitskiR. J. (2006). Relative efficacy of a multisession sexual risk-reduction intervention for young men released from prisons in 4 states. American Journal of Public Health, 96(10), 1854–1861. https://doi.org/10.2105/AJPH.2004.056044
